| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,630,000 |
| Market
Cap: |
26.95(M) |
| Last
Volume: |
204,752 |
Avg
Vol: |
427,496 |
| 52
Week Range: |
$0.6474 - $0.6474 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
216,159 |
| Total Buy Value |
$0 |
$0 |
$0 |
$108,668 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Drabik David A |
Director |
– • – |
2019-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
33,445 |
83,192 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2019-07-15 |
4 |
D |
$5.83 |
$11,124 |
D/D |
(1,908) |
29,220 |
|
- |
|
| Kozlowski John |
Chief of Staff & Strategy |
• – – |
2019-07-11 |
4 |
D |
$5.84 |
$2,721 |
D/D |
(466) |
23,788 |
|
- |
|
| Rewolinski Melissa |
Director |
– • – |
2019-07-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,785 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2019-07-01 |
4 |
D |
$6.05 |
$1,966 |
D/D |
(325) |
27,664 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2019-06-30 |
4 |
A |
$5.15 |
$7,910 |
D/D |
1,536 |
52,294 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2019-06-30 |
4 |
A |
$5.15 |
$4,635 |
D/D |
900 |
21,192 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2019-06-30 |
4 |
A |
$5.15 |
$7,534 |
D/D |
1,463 |
31,502 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2019-06-30 |
4 |
A |
$5.15 |
$4,311 |
D/D |
837 |
31,128 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2019-05-10 |
4 |
AB |
$6.85 |
$20,550 |
D/D |
3,000 |
50,758 |
|
- |
|
| Farber Jeffrey |
Director |
– • – |
2019-05-09 |
4 |
B |
$6.85 |
$68,500 |
D/D |
10,000 |
2,096,054 |
2.39 |
- |
|
| Lepore Patrick G |
Director |
– • – |
2019-05-08 |
4 |
B |
$7.32 |
$183,000 |
D/D |
25,000 |
142,895 |
2.39 |
- |
|
| Cavanaugh Maureen |
Senior Vice President and CCOO |
• – – |
2019-05-07 |
4 |
D |
$7.68 |
$18,317 |
D/D |
(2,385) |
21,253 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2019-04-30 |
4 |
D |
$7.69 |
$4,829 |
D/D |
(628) |
20,292 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2019-03-31 |
4 |
A |
$4.22 |
$8,676 |
D/D |
2,056 |
30,039 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2019-03-31 |
4 |
A |
$4.22 |
$3,815 |
D/D |
904 |
30,291 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2019-03-31 |
4 |
A |
$4.22 |
$7,469 |
D/D |
1,770 |
47,758 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2019-03-31 |
4 |
A |
$4.22 |
$3,979 |
D/D |
943 |
20,920 |
|
- |
|
| Lepore Patrick G |
Director |
– • – |
2019-02-12 |
4 |
B |
$8.93 |
$223,250 |
D/D |
25,000 |
117,895 |
2.39 |
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2019-02-11 |
4 |
AB |
$8.48 |
$33,920 |
D/D |
4,000 |
45,988 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2018-12-31 |
4 |
A |
$4.01 |
$4,636 |
D/D |
1,156 |
19,977 |
|
- |
|
| Chapman John C |
Director |
– • – |
2018-12-14 |
4 |
B |
$4.93 |
$49,300 |
D/D |
10,000 |
12,574 |
2.39 |
- |
|
| Lepore Patrick G |
Director |
– • – |
2018-12-13 |
4 |
B |
$5.10 |
$127,500 |
D/D |
25,000 |
92,895 |
2.39 |
- |
|
| Paonessa Albert Iii |
Director |
– • – |
2018-12-13 |
4 |
B |
$5.07 |
$50,700 |
D/D |
10,000 |
40,277 |
2.39 |
- |
|
| Farber Jeffrey |
Director |
– • – |
2018-12-12 |
4 |
B |
$5.32 |
$53,200 |
D/D |
10,000 |
2,086,054 |
2.39 |
- |
|
762 Records found
|
|
Page 8 of 31 |
|
|
